Kelle Brown turned devastating loss into a mission for earlier detection and patient advocacy. After losing her sister to diffuse gastric cancer and learning she carried the same CDH1 mutation, Kelle underwent a preventive gastrectomy that saved her life. Today, she mentors patients, advocates on Capitol Hill, and works to ensure others are diagnosed earlier and heard sooner.

Millions carry H. pylori without symptoms, yet long-term infection can raise the risk of stomach cancer. This article explains how the bacteria works, who is at risk, and why early detection with tools like DEX G2 is important for protecting your health.

Stomach cancer survivor and advocate Yoli Day shares how a life changing diagnosis led to major surgery, a new normal, and a powerful mission to support other patients. In this Stomach Cancer Awareness Month story, she reflects on survivorship, self advocacy, and the promise of earlier detection with tools like DEX-G2.

Lung cancer isn’t just a disease of older smokers. Cases are rising among young patients—especially women—who often face delayed diagnoses. Discover how early detection with CIZ1B can change outcomes.

Radon is an invisible threat that can raise your risk of lung cancer. This article explains how radon enters homes, why it is hard to detect, which action levels the EPA recommends, and practical steps for testing and mitigation. Learn how awareness and early detection protect families.

Wildfire smoke is more than a nuisance—it’s a serious health threat linked to lung cancer. Discover how Cizzle Bio’s CIZ1B test supports early detection for at-risk populations.

The American Lung Association is pushing for policy changes to expand insurance coverage for biomarker testing in lung cancer. Learn how Cizzle Bio is advancing early detection through its CIZ1B biomarker test.

Lung cancer is the leading cause of cancer-related deaths, but early detection can significantly improve survival rates. Discover how screening, including Cizzle Bio’s CIZ1B Biomarker Test, helps detect lung cancer in its earliest stages—when treatment is most effective.

Lung cancer often goes unnoticed until advanced stages. Learn how early detection with Cizzle Bio’s CIZ1B Biomarker Test can save lives and improve survival rates.

Lung cancer remains the leading cause of cancer deaths, but early detection offers hope. Discover how Cizzle Bio’s CIZ1B biomarker is revolutionizing diagnostics with non-invasive, accurate solutions.

Lung cancer affects one in six Americans and is the leading cause of cancer deaths. Learn about the critical importance of screenings and how Cizzle Bio, Inc. is pioneering early detection with innovative biomarker tests.

Discover the crucial role of lung cancer screening in early detection and improved survival rates. Learn about eligibility, benefits, risks, and the screening process to make informed decisions about your health.

Recent research highlights the ongoing challenges in lung cancer screening across the US, revealing low uptake rates and significant disparities. Cizzle Bio, Inc. is committed to addressing these challenges with our innovative CIZ1B biomarker test.

Delve into the significant barriers that hinder effective lung cancer screening and discover the strategies proposed to overcome these challenges to ensure early detection and better patient care.

Discover key insights on lung cancer from MD Anderson, including types, symptoms, risk factors, and treatment options. Learn why early detection and a multidisciplinary approach are crucial for effective treatment. Read more on MD Anderson's website.